Genome-wide association study on the development of cross-reactive neutralizing antibodies in HIV-1 infected individuals.
Broadly neutralizing antibodies may protect against HIV-1 acquisition. In natural infection, only 10-30% of patients have cross-reactive neutralizing humoral immunity which may relate to viral and or host factors. To explore the role of host genetic markers in the formation of cross-reactive neutral...
Main Authors: | Zelda Euler, Marit J van Gils, Brigitte D Boeser-Nunnink, Hanneke Schuitemaker, Daniëlle van Manen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3553002?pdf=render |
Similar Items
-
Cross-reactive broadly neutralizing antibodies: timing is everything
by: Zelda eEuler, et al.
Published: (2012-07-01) -
HIV-1 envelope glycoprotein characteristics that correlate with the development of cross-reactive neutralizing activity in HIV-1 infected individuals
by: van den Kerkhof TL, et al.
Published: (2012-09-01) -
Genome-wide association studies on HIV susceptibility, pathogenesis and pharmacogenomics
by: van Manen Daniëlle, et al.
Published: (2012-08-01) -
Genome-wide association scan in HIV-1-infected individuals identifying variants influencing disease course.
by: Daniëlle van Manen, et al.
Published: (2011-01-01) -
Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies.
by: Laura E McCoy, et al.
Published: (2015-08-01)